Pancytopenia in untreated patients with Graves' disease

Thyroid

Volumn 16, Issue 4, 2006, Pages 403-409

  Lima, Carmen S P ^a   Zantut Wittmann, Denise E ^a   Castro, Vagner ^a   Tambascia, Marcos A ^a   Lorand Metze, Irene ^a   Saad, Sara T O ^a   Costa, Fernando F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYMOCYTE ANTIBODY; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CASE REPORT; FEMALE; FREE THYROXINE INDEX; GRAVES DISEASE; HEMATOPOIESIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PANCYTOPENIA; PRIORITY JOURNAL; THYROTOXICOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; PANCYTOPENIA;

EID: 33646532419     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.403     Document Type: Article

References (40)

1. Ansell JE 1996 The blood in thyrotoxicosis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 7th ed., eds. Lippincott-Raven Publishers, Philadelphia, pp. 637-652.
2. DeGroot LJ 2004 Graves' disease and the manifestations of thyrotoxicosis-Hematologic changes. www.thyroidmanager. org/Chapter10/10-frame. htm (Last accessed March 3, 2006.)
3. Aoki N, Wakisaka G, Nagata I 1973 Increase of T cells in Graves' disease. Lancet 2:49-50.
4. Reddy J, Brownlie BEW, Heaton DC, Hamer JW, Turner JG 1981 The peripheral blood picture in thyrotoxicosis. N Z Med J 93:143-145.
5. Aanderud S, Matre R, Varhaug JE 1982 Immunological characterization of mononuclear cells in thyroid gland and blood in Graves' disease, multinodular goiter and papillary carcinoma. Int Arch Allergy Appl Immunol 69:137-142.
6. Hymes K, Blum M, Lackner H, Karpatkins S 1981 Easy bruising, thrombocytopenia and elevated platelet immunoglobulin G in Graves' disease and Hashimoto thyroiditis. Ann Intern Med 94:27-30.
7. Juvara I, Radulescu D 1971 Hyperthyroidie et pancytopénie, traitement chirurgical. Presse Med 13:581.
8. Bertola G, Bocchia M, Ribotto P, Orlandini G, Torchio G 1998 Alterazioni ematologiche in corso di ipertiroidismo. Descrizione di un caso. Recenti Prog Med 89:180-182.
9. Iguchi H, Nakano M 1983 Case of hyperthyroidism with pancytopenia. Nippon Naibunpi Gakkai Zasshi 144:1117-1122.
10. Duquenne M, Lakomsky D, Humbert JC, Hadjadj S, Weryha G, Leclère J 1995 Pancytopénie résolutive par le traitement d'une hyperthyroidie. Presse Med 24:807-810.
11. Soeki T, Tamura Y, Kondo N, Shinohara H, Tanaka T, Bando K, Fukuda N 2001 A case of thyrotoxicosis with pancytopenia. Endocr J 48:385-389.
12. Shaw B, Mehta AB 2002 Pancytopenia responding to treatment of hyperthyroidism: A clinical case and review of the literature. Clin Lab Haematol 24:385-387.
13. Kroll H, Sun QH, Santoso S 2000 Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood 96:1409-1414.
14. Marsh JC, Ball SE, Derbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, McCann SR, Mercieca J, Oscier D, Roques AW, Yin JA 2003 British Committee for Standards in Haematology. Blood 123:782-801.
15. Ladwig P, Coles R, Fisher E, Spurrett B 1995 Thyrotoxicosis in pregnancy presenting as pancytopenia. Aust N Z J Obstet Gynaecol 35:457-460.
16. Das KC, Mukherjee M, Sarkar TK, Dash RJ, Rastogi GK 1975 Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 40:211-220.
17. Boitard C, Anciaux-Lespine ML, Eugène C, Quevauvilliers J 1979 Anémie et microcytosis au cours de la maladie de Basedow. Discussion physio-pathologique. Nouv Presse Med 8:499-502.
18. Klein M, Weryha G, Kaminsky P, Duc M, Leclère J 1993 Les manifestations hèmatologiques des hyperthyroidies. Ann Med Interne 144:127-135.
19. Macaron CI, Macaron ZG 1982 Increased serum ferritin levels in hyperthyroidism. Ann Intern Med 96:617-618.
20. Kuhn JM, Rieu M, Wolf LM, Courtois H, Bricaire H, Luton JP 1984 Répercussions hématologiques des troubles de la sécrétion thyroidienne. Presse Med 13:421-425.
21. Burns RW, Burns TW 1996 Pancytopenia due to vitamin B12 deficiency associated with Graves' disease. Mo Med 93:368-372.
22. Lahtinen R 1980 Sideroblasts and haemosiderin in thyrotoxicosis. Scand J Haematol 25:237-243.
23. Brown JG, Millward DJ 1983 Dose response of protein turnover in rat skeletal muscle to triiodothyronine treatment. Biochim Biophys Acta 757:182-190.
24. Everts ME, Hardeveld C, Ter Keurs HE, Kassenaar AA 1983 Force development and metabolism in perfused skeletal muscle of euthyroid and hyperthyroid rats. Horm Metab Res 15:388-393.
25. McCullagh EP, Dunlap JH 1931 The blood picture in hyperthyroidism and in hypothyroidism. J Lab Clin Med 17:1060-1070.
26. Bistrom O 1946 On the morphology of blood and bone marrow in thyrotoxicosis. Acta Chir Scand 94:1-188.
27. Eakin DL, Peake RL, Weiss GB 1983 Effect of therapy on the neutropenia of hyperthyroidism. South Med J 76:335-340.
28. Weitzman AS, Stossel TP, Harmon DC, Daniels G, Maloof F, Ridgway EC 1985 Antineutrophil antibodies in Graves' disease. Implications of thyrotropin binding to neutrophils. J Clin Invest 75:119-123.
29. Ponassi A, Morra L, Caristo G, Parodi GB, Biassoni P, Sacchetti C 1983 Disorders of granulopoiesis in patients with untreated Graves' disease. Acta Haematol 70:19-23.
30. Woodruff P 1940 The behavior of blood platelets in thyrotoxicosis. Med J Aust 2:190.
31. Kurata Y, Nishioeda Y, Tadahiro T, Kitani T 1980 Thrombocytopenia in Graves' disease: Effect of T3 on platelet kinetics. Acta Haematol 63:185-190.
32. Adrouny A, Sandler RM, Carmel R 1982 Variable presentation of thrombocytopenia in Graves' disease. Arch Intern Med 142:1460-1464.
33. Lamberg BA, Kivikangas V, Pelkonen R, Vuopio P 1971 Thrombocytopenia and decreased life-span of thrombocytes in hyperthyroidism. Ann Clin Res 3:98-102.
34. Panzer S, Haubenstock A, Minar E 1990 Platelets in hyperthyroidism. Studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. J Clin Endocrinol Metab 70:491-496.
35. Martelo OJ, Katims RB, Yunis AA 1967 Bone marrow aplasia following propylthiouracil therapy. Report of a case with complete recovery. Arch Intern Med 120:587-590.
36. Biswas N, Ahn Y-H, Goldman JM, Schwartz JM 1991 Case report: Aplastic anemia associated with antithyroid drugs. Am J Med Sci 301:190-194.
37. Escobar-Morreale HF, Bravo P, Garcia-Robles R, Garcia-Larana J, La Calle H, Sancho JM 1997 Methimazole-induced severe aplastic anemia: Unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor. Thyroid 7:67-70.
38. Cooper DS 2005 Antithyroid drugs. N Engl J Med 352:905-917.
39. Haq MS, McCready RV, Harmer CL 2004 Treatment of advanced differentiated thyroid carcinoma with high activity radioiodine therapy. Nucl Med Commun 25:799-805.
40. Read CH Jr, Tansey MJ, Menda Y 2004 A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 89:4229-1233.